SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SU Group Holdings Ltd. engages in the provision of security-related engineering services, and security guarding and screening services. It operates through the Security-Related Engineering Services and Security Guarding and Screening Services segments. The company was founded by Ming Chan in 1998 and is headquartered in Hong Kong.

SU Group Holdings Ltd. - Ordinary Shares - Class A

SU Group Holdings Ltd.

SUGP is trending as traders discuss its low float and potential for a short squeeze, drawing comparisons to other Hong Kong-based stocks that have recently seen significant gains. Community members are pointing to the company's regained NASDAQ compliance and a substantial contract that exceeds its market capitalization as potential catalysts. The high cost to borrow is also fueling speculation about a potential squeeze.

Firecoin is a digital asset inspired by the concept of the eternal flame, representing energy, resilience, and guidance. It is designed to act as a decentralized token that embodies light and strength, giving holders a sense of empowerment in the digital economy. The project’s purpose is to create a community-driven ecosystem where Firecoin symbolizes progress, illumination, and the ability to move forward regardless of challenges. By leveraging blockchain technology, Firecoin aims to provide transparency, security, and accessibility to its users while maintaining its thematic connection to the symbolic power of fire.

firecoin

$FIRECOIN is gaining attention, particularly among Phantom Wallet users, with discussions focusing on its potential for significant gains. Community members are debating whether it's still early to invest, while others are wary, pointing to potential risks and comparing it to other trending coins on the Solana blockchain. The conversation includes speculation around potential 'pump and dump' dynamics.

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company. It engages in the treatment of mental health disorders. The company was founded by Christian Angermayer, Florian Brand, Srinivas Rao and Lars Christian Wilde in June 2018 and is headquartered in Amstelveen, Netherlands.

ATAI Life Sciences N.V.

ATAI is trending due to positive phase 2 trial results for its depression treatment, BPL-003, leading to community excitement and discussions about its potential in the psychedelic medicine space. Investors are particularly focused on the possibility of FDA breakthrough therapy designation and upcoming data releases, while also debating the implications of the Beckley Psytech merger. Some community members are expressing concerns around dilution while others are looking at technical analysis to determine entry points.

Stonks is the first ever memecoin on the Solana blockchain.   Verifiably deployed in block 71935764 on April 02, 2021 22:10:10 UTC.  On 2024-11-24 members of the community banded together and purchased the website, Twitter, GitHub and developer coins from the original team, making it 100% community owned.  Liquidity has been locked and the community is committed to ensuring the revival of the project

Stonks

$STNK is trending as the first memecoin on Solana, backed by the iconic 'Stonks' meme IP, driving community excitement. With a limited supply, the community emphasizes its historical significance and potential, noting its unique position in the meme coin landscape. Discussions highlight the cultural relevance of the meme and the potential for significant growth.

Delcath Systems, Inc. is an oncology company, which engages in the treatment of primary and metastatic liver cancers. Its products include CHEMOSAT and HEPZATO. The company was founded on August 5, 1988 and is headquartered in Queensbury, NY.

Delcath Systems Inc

Delcath Systems is trending as investors anticipate upcoming data from the CHOPIN trial, with the presentation at ESMO being a key event for the company. Community members are closely watching for signals about the trial's outcome, with some suggesting positive results are expected, while others discuss potential revenue impacts and the possibility of a buyout. The stock's trading activity and recent price movements are also a central focus of discussion.

Solana Co. is a neurotech company in the medical device industry that focuses on neurological wellness. The firm develops, licenses and acquires non-invasive platform technologies that amplify the brain’s ability to heal itself and reduce symptoms of neurological disease or trauma. It engages in the development of the investigational portable neuromodulation stimulator, that delivers neurostimulation via the tongue which has been shown in clinical studies to enhance the effectiveness of physical exercises in people with neurological symptoms from disease or trauma such as mild-to-moderate traumatic brain injury. The company was founded on March 13, 2014 and is headquartered in Newtown, PA.

Solana Co. - Ordinary Shares - Class A

Solana Co

HSDT is trending due to news of a significant funding round to establish a Solana-backed treasury, leading to high volatility as the community debates the company's shift in focus.  Community members are actively discussing short squeeze potential, possible price targets, and the impact of Solana's performance on HSDT. The stock's movements are also being compared to those of other crypto-related stocks, with some cautioning about potential dilution.

Bitfarms Ltd. (Canada) engages in the business of mining cryptocurrency. The firm is also involved in the ownership and operation of server farms comprised of computers designed for the purpose of validating transactions on the Bitcoin blockchain. The company was founded by Emiliano Joel Grodzki and Nicolas Bonta in 2017 and is headquartered in Toronto, Canada.

Bitfarms Ltd.

BITF is trending due to discussions around a recently upsized convertible senior note offering, with the community debating its implications on dilution and future growth. Some view the offering as a strategic move to fund expansion, particularly into AI infrastructure, while others express concerns about short-term price impact. The stock's after-hours recovery and upcoming CEO space on X are also fueling conversation.

Concord Medical Services Holdings Ltd. engages in the provision of operation of radiotherapy and diagnostic imaging centers. It operates through Network Business and Hospital Business segments. It provides radiotherapy and diagnostic equipment leasing services to hospitals, and sale of medical equipment and the provision of radiotherapy and diagnostic equipment leasing and management services to hospitals. The company was founded on November 27, 2007 and is headquartered in Beijing, China.

Concord Medical Services - ADR

Concord Medical Services Holdings Limited

CCM is trending as traders compare it to other low-float Hong Kong stocks that have experienced significant short squeezes. Community members are highlighting the stock's potential for a substantial run, pointing to its low float and high cost to borrow. Recent news around AIoT car parking is also circulating among traders.

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Chatham, NJ.

Tonix Pharmaceuticals Holding Corp

TNXP is trending as investors discuss recent institutional buying by BlackRock, sparking speculation about potential positive news or a major partnership. The community is weighing the potential for a significant upside against concerns about past dilutions and the company's overall management, particularly as it relates to the launch of Tonmya. Discussions also revolve around the commercial strategy for Tonmya, its pricing, and potential partnerships for wider distribution.

Addex Therapeutics Ltd. is a biopharmaceutical company, which engages in the development of drugs for human health. It develops novel, orally available, and small molecule allosteric modulators for neurological disorders. Its pipeline includes Dipraglurant, ADX71149, GABAB PAM, mGlu7 NAM, mGlu2 NAM, mGlu4 PAM, and mGlu3 PAM. The company was founded by Vincent Mutel, Timothy Dyer, and Mark Epping-Jordan in 2002 and is headquartered in Geneva, Switzerland.

Addex Therapeutics Ltd - ADR

Addex Therapeutics ($ADXN) is trending as traders react to news of clinical candidate selection in their GABAB collaboration with Indivior, potentially unlocking $330M in milestone payments and royalties. The community is actively discussing the stock's low float and potential for a significant short squeeze, with some expressing concerns about potential pullbacks. Bullish sentiment is building, with many eyeing the stock's potential to reach significantly higher price levels.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Value Line's Q1 Earnings Rise Y/Y Despite Lower Publishing Revenues

VALU posts year-over-year growth in Q1 earnings, fueled by asset management income and investment gains, even as core publishing revenue declines slightly.

Value Line's Q4 Earnings Fall Y/Y on Print Revenue Decline

Value Line's Q4 earnings fall year over year to 42 cents per share, pressured by declining print subscriptions and higher operating costs, though strong EAM distributions provided some respite. 

KraneShares Value Line  Dyn Div Eq ETF (KVLE, $23.98) RSI Indicator left the overbought zone on April 01, 2024

This is a signal that KVLE's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...

Value Line (NASDAQ:VALU) Earns Hold Rating from Analysts at StockNews.com

Equities research analysts at StockNews.com assumed coverage on shares of Value Line (NASDAQ:VALU - Get Free Report) in a note issued to investors on Monday. The firm set a "hold" rating on the...

KraneShares Value Line  Dyn Div Eq ETF (KVLE, $24.13) RSI Indicator left the overbought zone on March 28, 2024

First Trust Value Line Dividend Index Fund Experiences Big Outflow

Symbols mentioned in this story: FVD, GRMN, SWX, KR

 Exchange traded funds (ETFs) trade just like stocks, but instead of shares investors are actually buying and selling...

First Trust Value Line  Dividend ETF (FVD, $42.01) price may drop as it broke higher Bollinger Band on Mar 27, 2024

This price move could be a signal that FVD may fall back below the higher band and head toward the middle band. Traders may consider selling the stock, shorting the stock, or exploring put options...

First Trust Value Line  Dividend ETF (FVD, $42.01) Moving Average Convergence Divergence (MACD) Histogram turned positive on March 27, 2024

This is a Bullish indicator signaling FVD's price could rise from here. Traders may explore going long the stock or buying call options...

First Trust Value Line  Dividend ETF (FVD, $42.01) RSI Indicator left the overbought zone on March 27, 2024

This is a signal that FVD's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...

KraneShares Value Line  Dyn Div Eq ETF (KVLE, $23.97) RSI Indicator left the overbought zone on March 20, 2024

Value Line, Inc. engages in the provision of investment research. It produces investment periodicals based on underlying research and making available copyright data, including certain proprietary ranking system and other proprietary information, to third parties under written agreements for use in third-party managed and marketed investment products and for other purposes. The company was founded by Arnold Bernhard in 1931 and is headquartered in New York, NY.

Value Line, Inc.

Will Netflix ($NFLX) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

Netflix Inc

) beat quarterly earnings? 
 
*Powered by Polymarket

Current Price	$38.45
Prev Close	$38.93
Open	$38.44
Dividend Yield	3.00%
50-Day Moving Average	$38.37
Beta	0.69
Avg. Volume	6,277.38
PE Ratio	17.24

52-Week High	$57.68
52-Week Low	$32.94
Market Capitalization	$366.25M
EPS (Annual)	$2.20
Price to Book	3.56
Revenue Per Employee	$299,820.51
Enterprise Value/EBITDA	N/A

VALU
Value Line, Inc.

Feed

News

Sentiment

Fundamentals

Info

Latest VALU News

VALUValue Line, Inc.